Heidelberg Pharma AG filed its Annual on Mar 24, 2023 for the period ending Nov 30, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
After market 01:00:36 pm | |||
2.97 EUR | 0.00% | 2.945 | -0.84% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 150M | |
+10.28% | 114B | |
+12.93% | 107B | |
-5.39% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.61% | 17.51B | |
-39.36% | 17.17B | |
+7.35% | 14.14B | |
+34.66% | 12.2B |
- Stock Market
- Equities
- HPHA Stock
- News Heidelberg Pharma AG
- Heidelberg Pharma AG Auditor Raises 'Going Concern' Doubt